Reference:
AHAJournals Title: Arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia: Insights from a RyR2 R4496C knock-in mouse model. Circ Res. 2006 Aug 4;99(3):292-8.
Author: Liu N, Colombi B, Memmi M, Zissimopoulos S, Rizzi N, Negri S, Imbriani M, Napolitano C, Lai FA, Priori SG.

Reference:
Circ Res Title: Arrhythmogenic mechanisms in a mouse model of catecholaminergic polymorphic ventricular tachycardia. Circ Res. 2007 Nov 9;101(10):1039-48.
Author: Cerrone M, Noujaim SF, Tolkacheva EG, Talkachou A, O'Connell R, Berenfeld O, Anumonwo J, Pandit SV, Vikstrom K, Napolitano C, Priori SG, Jalife J.

Reference:
J Physiol Title: Local calcium release activation by DHPR calcium channel openings in rat cardiac myocytes. J Physiol. 2008 Aug 15;586(16):3839-54. 
Author: Poláková E, Zahradníková A Jr, Pavelková J, Zahradník I, Zahradníková A.

Reference:
Circ Res Title: Increased Ca²⁺ Sensitivity of the Ryanodine Receptor Mutant RyR2^R4496C Underlies Catecholaminergic Polymorphic Ventricular Tachycardia. Circ Res. 2009;104:201-9.
Author: Fernández-Velasco M, Rueda A, Rizzi N, Benitah JP, Colombi B, Napolitano C, Priori SG, Richard S, Gómez AM.

Reference:
PubMed Title: Arrhythmogenic mechanisms in a mouse model of catecholaminergic polymorphic ventricular tachycardia. Circ Res. 2007;101:1039-48.
Author: Cerrone M, Noujaim SF, Tolkacheva EG, Talkachou A, O'Connell R, Berenfeld O, Anumonwo J, Pandit SV, Vikstrom K, Napolitano C, Priori SG, Jalife J.

Reference:
Pubmed Title: A mechanism of ryanodine receptor modulation by FKBP12/12.6, Protein Kinase A and K201. Cardiovasc Res. 2009 Sep 2. [Epub ahead of print].
Author: Blayney LM, Jones JL, Griffiths J, Lai FA.

Reference:
Circulation Title: Mineralocorticoid modulation of cardiac ryanodine receptor activity is associated with downregulation of FK506-binding proteins. Circulation. 2009;119(16):2179-87.
Author: Gómez AM, Rueda A, Sainte-Marie Y, Pereira L, Zissimopoulos S, Zhu X, Schaub R, Perrier E, Perrier R, Latouche C, Richard S, Picot MC, Jaisser F, Lai FA, Valdivia HH, Benitah JP.

Reference:
Pubmed Title: FKBP12.6 binding of ryanodine receptors carrying mutations associated with arrhythmogenic cardiac disease. Biochem J. 2009;419(2):273-8.
Author: Zissimopoulos S, Thomas NL, Jamaluddin WW, Lai FA.

Reference:
Cell Calcium Title: Modification of smooth muscle Ca2+-sparks by tetracaine: evidence for sequential RyR activation. Cell Calcium. 2008;43(2):142-54.
Author: Curtis TM, Tumelty J, Stewart MT, Arora AR, Lai FA, McGahon MK, Scholfield CN, McGeown JG.

Reference:
Circ Res Title: Alternative splicing of ryanodine receptors modulates cardiomyocyte Ca2+ signaling and susceptibility to apoptosis. Circ Res. 2007;100(6):874-83.
Author: George CH, Rogers SA, Bertrand BM, Tunwell RE, Thomas NL, Steele DS, Cox EV, Pepper C, Hazeel CJ, Claycomb WC, Lai FA.

Reference:
JBC Title: Redox sensitivity of the ryanodine receptor interaction with FK506-binding protein. J Biol Chem. 2007;282(10):6976-83.
Author: Zissimopoulos S, Docrat N, Lai FA

Reference:
Am J Cardiol Title: Relation of increased short-term variability of QT interval to congenital long-QT syndrome. Am J Cardiol. 2009;103:1244-8.
Author: 1. Hinterseer M, Beckmann BM, Thomsen MB, Pfeufer A, Dalla Pozza R, Loeff M, Netz H, Steinbeck G, Vos MA, Kääb S

Reference:
Eur Heart J Title: Beat-to-beat variability of QT intervals is increased in patients with drug-induced long-QT syndrome: a case control pilot study. Eur Heart J. 2008;29:185-90
Author: 2. Hinterseer M, Thomsen MB, Beckmann BM, Pfeufer A, Schimpf R, Wichmann HE, Steinbeck G, Vos MA, Kääb S.

Title: ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary:  Eur Heart J. 2006 Sep;27(17):2099-140.
Author: 13. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG et al.